Ra Capital Management, L.P. Ardelyx, Inc. Transaction History

Ra Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $7.72 Million - $49.7 Million	-6,077,294 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $523,331 - $659,740	-85,792 Reduced 1.39%	6,077,294 $40.2 Million
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $493,980 - $694,507	-97,818 Reduced 1.56%	6,163,086 $39.9 Million
Q2 2020 Aug 14, 2020	SELL	$5.37 - $8.11 $836,538 - $1.26 Million	-155,780 Reduced 2.43%	6,260,904 $43.3 Million
Q1 2020 May 15, 2020	BUY	$4.35 - $8.79 $4.6 Million - $9.3 Million	1,057,821 Added 19.74%	6,416,684 $36.5 Million

Q4 2019 Feb 14, 2020	BUY	$4.23 - $8.29 $22.7 Million - $44.4 Million	5,358,863 New	5,358,863 $40.2 Million

197

140M

1.25M

1.52M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $1.15B
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.